Studies aimed to investigate the role of PepT1, a di/tripeptide transporter, in mediating the anti-inflammatory effects of KPV in intestinal epithelial and immune cells
Efpeglenatide and clinical outcomes with and without concomitant sodium-glucose cotransporter-2 inhibition use in type 2 diabetes: exploratory analysis of the AMPLITUDE-O trial
Az eredmnyek szerint a pektin hatsa rszben kzvetlen, rszben a mikrobiota kzvettsvel valsul meg
After synthesizing nanoparticles, the first step was to determine the shape, purity, and phase of the as-prepared nanoparticles
En gnral, une rduction significative du volume est toujours possible
BMJ Open Diabetes Research & Care, 8(2), e001706